Cargando…
Randomized Blinded Placebo-Controlled Trials of Renal Sympathetic Denervation for Hypertension: A Meta-Analysis
BACKGROUND: The efficacy of renal denervation has been controversial, but the procedure has now undergone several placebo-controlled trials. New placebo-controlled trial data has recently emerged, with longer follow-up of one trial and the full report of another trial (which constitutes 27% of the t...
Autores principales: | Ahmad, Yousif, Kane, Christopher, Arnold, Ahran D., Cook, Christopher M., Keene, Daniel, Shun-Shin, Matthew, Cole, Graham, Al-Lamee, Rasha, Francis, Darrel P., Howard, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813172/ https://www.ncbi.nlm.nih.gov/pubmed/33551282 http://dx.doi.org/10.1016/j.carrev.2021.01.031 |
Ejemplares similares
-
Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
por: Chacko, Liza, et al.
Publicado: (2020) -
Cardiac Rhythm Device Identification Using Neural Networks
por: Howard, James P., et al.
Publicado: (2019) -
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
por: Nowbar, Alexandra N, et al.
Publicado: (2021) -
Renal Sympathetic Denervation for Hypertension
por: Guber, Kenneth, et al.
Publicado: (2022) -
Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta‐Analysis of Randomized Trials
por: Ahmad, Yousif, et al.
Publicado: (2020)